Fabagal^®

Description

A drug for therapy of the orphan Fabry disease.

Application

For long-term enzyme replacement therapy of patients with confirmed diagnosis of Fabry disease (a rare genetically determined disease, causing kidney problems, neuropathic limb pain, congestive heart failure and stroke).

Active ingredients

Agalsidase beta.